Disclosures for "Validating Patient Symptoms in the Electronic Health Record with Large Language Models for Scalable Tracking of Symptoms in Neuro-oncology"
-
Dr. Rhee has stock in NTAP. Dr. Rhee has stock in TSLA. Dr. Rhee has stock in BABA. Dr. Rhee has stock in ZM. Dr. Rhee has stock in GM. Dr. Rhee has stock in PFF. Dr. Rhee has stock in AMZN. Dr. Rhee has stock in META. Dr. Rhee has stock in GE. The institution of Dr. Rhee has received research support from American Academy of Neurology. Dr. Rhee has received personal compensation in the range of $0-$499 for serving as a Director of the Hippocratic Forum with Hippocratic Society.
-
Mr. Sounack has nothing to disclose.
-
Mr. Tentor has nothing to disclose.
-
Mr. Davis has nothing to disclose.
-
Miss Durieux has nothing to disclose.
-
Mr. Miller has received personal compensation for serving as an employee of Hillsdale College. Mr. Miller has stock in AGRO. Mr. Miller has stock in AMPY. Mr. Miller has stock in CEG. Mr. Miller has stock in GSM. Mr. Miller has stock in MP. Mr. Miller has stock in PGHL. Mr. Miller has stock in SARO. Mr. Miller has stock in SXC. Mr. Miller has stock in TK. Mr. Miller has stock in OSTX.
-
An immediate family member of Dr. Beroukhim has received personal compensation for serving as an employee of Moderna. Dr. Beroukhim has received personal compensation in the range of $100,000-$499,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Scorpion Therapeutics. Dr. Beroukhim has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Daiichi Sankyo. Dr. Beroukhim has stock in Takeda. Dr. Beroukhim has stock in Karyoverse Therapeutics. The institution of Dr. Beroukhim has received research support from Novartis. The institution of Dr. Beroukhim has received research support from NIH. Dr. Beroukhim has received personal compensation in the range of $500-$4,999 for serving as a Grant reviewer with NIH. Dr. Beroukhim has received personal compensation in the range of $500-$4,999 for serving as a Grant reviewer with Ohio State University. Dr. Beroukhim has received personal compensation in the range of $500-$4,999 for serving as a Advisory Board Member with DKFZ.
-
The institution of Dr. Lindvall has received research support from National Institutes of Health.